Stroes, Charlotte I ;
Schokker, Sandor ;
Molenaar, Remco J...
Stroes , C I , Schokker , S , Molenaar , R J , Mathôt , R A A , Bijlsma , M F , van der Woude , S O , Pereira , J P B , Hooijer , G K J , Verhoeven , R H A , Cats , A , Grootscholten , C , van Sandick , J W , Creemers , G-J , Nieuwenhuijzen , G A P , Mohammad , N H , Ruurda , J P , Meijer , S L , Hulshof , M C C M , Henegouwen , M I V B & van Laarhoven , H W M 2021 , ' A phase ii study demonstrates no feasibility of adjuvant treatment with six cycles of s-1 and oxaliplatin in resectable esophageal adenocarcinoma, with ercc1 as biomarker for response to sox ' , Cancers , vol. 13 , no. 4 , 839 , pp. 1-15 . https://doi.org/10.3390/cancers13040839.
,
2021
